National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group

Author:

Kawaguchi Hiroki1ORCID,Soejima Toshinori2,Ishibashi Naoya3ORCID,Akiba Takeshi4,Hasegawa Masatoshi5,Isobe Kouichi6,Ito Hitoshi7,Imai Michiko8,Ejima Yasuo9ORCID,Hata Masaharu10ORCID,Sasai Keisuke11,Shimoda Emiko5,Oguchi Masahiko12,Akimoto Tetsuo13

Affiliation:

1. Division of Radiation Oncology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo, Japan

2. Department of Radiation Oncology, Kobe Proton Center, Kobe, Japan

3. Department of Radiology, Nihon University School of Medicine, Tokyo, Japan

4. Department of Radiation Oncology, Tokai University, Isehara, Japan

5. Department of Radiation Oncology, Nara Medical University, Kashihara, Japan

6. Department of Radiology, Toho University Sakura Medical Center, Chiba, Japan

7. Department of Radiation Oncology, Kyoto Katsura Hospital, Kyoto, Japan

8. Department of Radiology, Iwata City General Hospital, Iwata, Japan

9. Department of Radiology, Dokkyo Medical University, Tochigi, Japan

10. Division of Radiation Oncology, Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

11. Department of Radiation Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan

12. Department of Radiation Oncology, The Cancer Institution Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

13. Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan

Abstract

AbstractReduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the administration of TBI–RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI–RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI–RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI–RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI–RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI–RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI–RIST in Japan and can assist future efforts to standardize TBI–RIST treatment methods and to design a future multicenter collaborative research study.

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Radiology, Nuclear Medicine and imaging,Radiation

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3